(Q44600843)

English

Hydrochlorothiazide abolishes the anti‐atherosclerotic effect of quinapril

scientific article published on October 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hydrochlorothiazide abolishes the anti‐atherosclerotic effect of quinapril (English)

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

atherosclerosis

1 reference

based on heuristic

inferred from title

hydrochlorothiazide

1 reference

based on heuristic

inferred from title

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Francisco Fonseca

1

object named as

F. A H. Fonseca

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14516418

15 March 2024

Maria Cristina Izar

3

object named as

M. C O. Izar

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14516418

15 March 2024

author name string

Fonseca FA

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Ihara SS

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Izar MC

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Lopes IE

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Pinto LE

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

de Paola AA

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Carvalho AC

11

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

S. S M. Ihara

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14516418

15 March 2024

E. P. Silva

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14516418

15 March 2024

N. Kasinski

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14516418

15 March 2024

I. E L. Lopes

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14516418

15 March 2024

L. E S A. Pinto

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14516418

15 March 2024

T. B. Paiva

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14516418

15 March 2024

S. Tufik

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14516418

15 March 2024

A. A V. de Paola

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14516418

15 March 2024

A. C C. Carvalho

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14516418

15 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14516418

15 March 2024

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1440-1681.2003.03911.x

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1440-1681.2003.03911.x

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Clinical and Experimental Pharmacology and Physiology

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

779-785

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Early benefits of pravastatin to experimentally induced atherosclerosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Molecular cloning and expression of rat squalene epoxidase

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Identification in the calcineurin A subunit of the domain that binds the regulatory B subunit

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition: mechanistic evidence to support RALES

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Antioxidant properties of indapamide, 5-OH indapamide and hydrochlorothiazide evaluated by oxygen-radical absorbing capacity and electron paramagnetic resonance

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2003.03911.X

21 January 2018

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

2

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

3

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Angiotensin-converting enzyme inhibitors in patients with coronary atherosclerosis

7

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Increased activity of vascular ACE related to atherosclerotic lesions in hyperlipidemic rabbits

8

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

The Role of Endothelium in Cardiovascular Homeostasis and Diseases

11

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

16

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level

20

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta

22

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells

23

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Hypercholesterolemia increases endothelial superoxide anion production

24

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Kinins mediate kallikrein-induced endothelium-dependent relaxations in isolated canine coronary arteries

27

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Kinins and endothelial control of vascular smooth muscle

31

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Effects of diuretics on renal kallikrein gene expression in rats

32

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies

34

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

35

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Pathophysiology and treatment implications of hypertension in the African-American population

37

1 reference

10.1046/J.1440-1681.2003.03911.X

https://api.crossref.org/works/10.1046/J.1440-1681.2003.03911.X

15 March 2024

Identifiers

10.1046/J.1440-1681.2003.03911.X

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

release_ogzdsdh2zfduxieow6oyutysfe

1 reference

https://api.fatcat.wiki/v0/release/ogzdsdh2zfduxieow6oyutysfe

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44600843&oldid=2102621431"